This map shows the geographic impact of M Katano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Katano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Katano more than expected).
This network shows the impact of papers produced by M Katano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Katano. The network helps show where M Katano may publish in the future.
Co-authorship network of co-authors of M Katano
This figure shows the co-authorship network connecting the top 25 collaborators of M Katano.
A scholar is included among the top collaborators of M Katano based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M Katano. M Katano is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Morisaki, Takashi, K. Hashizume, Takashi Yao, et al.. (2001). Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.. PubMed. 7(12). 4136–42.182 indexed citations
5.
Katano, M, et al.. (1999). The past, the present and future of the OK-432 therapy for patients with malignant effusions.. PubMed. 18(5D). 3917–25.41 indexed citations
Mashima, Hirosato, et al.. (1992). [Intra-arterial chemotherapy with granulocyte colony-stimulating factor for breast cancer before surgical treatment].. PubMed. 19(10 Suppl). 1609–12.
13.
Torisu, Motomichi, Takeshi Goya, Kazunori Iwasaki, et al.. (1991). [Eighteen-year experience of cancer immunotherapies--evaluation of their therapeutic benefits and future].. PubMed. 92(9). 1212–6.1 indexed citations
14.
Hidaka, Katsuhiko, Hiroshi Yamamoto, Shusaku Harada, et al.. (1988). [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].. PubMed. 41(9). 1295–303.3 indexed citations
15.
Katano, M, et al.. (1987). [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].. PubMed. 88(12). 1676–83.1 indexed citations
Katano, M, et al.. (1984). Human monoclonal antibody to tumor-associated ganglioside GD2.. PubMed. 15(3). 119–26.12 indexed citations
18.
Katano, M & Motomichi Torisu. (1983). New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.. PubMed. 93(3). 365–73.76 indexed citations
19.
Katano, M, et al.. (1980). Ambidextrous effect of psk on motilities of both macrophages and tumor cells. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 476.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.